Cargando…
The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling
Brain insulin signaling is accounted for the development of a variety of neuropsychiatric disorders, such as anxiety and depression, whereas both inflammation and the activated renin-angiotensin system (RAS) are two major contributors to insulin resistance. Intriguingly, inflammation and RAS can act...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454872/ https://www.ncbi.nlm.nih.gov/pubmed/31001119 http://dx.doi.org/10.3389/fphar.2019.00318 |
_version_ | 1783409620953333760 |
---|---|
author | Gong, Xiaoxue Hu, Hui Qiao, Yi Xu, Pengfei Yang, Mengqi Dang, Ruili Han, Wenxiu Guo, Yujin Chen, Dan Jiang, Pei |
author_facet | Gong, Xiaoxue Hu, Hui Qiao, Yi Xu, Pengfei Yang, Mengqi Dang, Ruili Han, Wenxiu Guo, Yujin Chen, Dan Jiang, Pei |
author_sort | Gong, Xiaoxue |
collection | PubMed |
description | Brain insulin signaling is accounted for the development of a variety of neuropsychiatric disorders, such as anxiety and depression, whereas both inflammation and the activated renin-angiotensin system (RAS) are two major contributors to insulin resistance. Intriguingly, inflammation and RAS can activate each other, forming a positive feedback loop that would result in exacerbated unwanted tissue damage. To further examine the interrelationship among insulin signaling, neuroinflammation and RAS in the brain, the effect of repeated lipopolysaccharide (LPS) exposure and co-treatment with the angiotensin II (Ang II) receptor type 1 (AT1) blocker, candesartan (Cand), on anxiety and depression-like behaviors, RAS, neuroinflammation and insulin signaling was explored. Our results demonstrated that prolonged LPS challenge successfully induced the rats into anxiety and depression-like state, accompanied with significant neural apoptosis and neuroinflammation. LPS also activated RAS as evidenced by the enhanced angiotensin converting enzyme (ACE) expression, Ang II generation and AT1 expression. However, blocking the activated RAS with Cand co-treatment conferred neurobehavioral protective properties. The AT1 blocker markedly ameliorated the microglial activation, the enhanced gene expression of the proinflammatory cytokines and the overactivated NF-κB signaling. In addition, Cand also mitigated the LPS-induced disturbance of insulin signaling with the normalized phosphorylation of serine 307 and tyrosine 896 of insulin receptor substrate-1 (IRS-1). Collectively, the present study, for the first time, provided the direct evidence indicating that the inflammatory condition may interact with RAS to impede brain insulin pathway, resulting in neurobehavioral damage, and inhibiting RAS seems to be a promising strategy to block the cross-talk and cut off the vicious cycle between RAS and immune system. |
format | Online Article Text |
id | pubmed-6454872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64548722019-04-18 The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling Gong, Xiaoxue Hu, Hui Qiao, Yi Xu, Pengfei Yang, Mengqi Dang, Ruili Han, Wenxiu Guo, Yujin Chen, Dan Jiang, Pei Front Pharmacol Pharmacology Brain insulin signaling is accounted for the development of a variety of neuropsychiatric disorders, such as anxiety and depression, whereas both inflammation and the activated renin-angiotensin system (RAS) are two major contributors to insulin resistance. Intriguingly, inflammation and RAS can activate each other, forming a positive feedback loop that would result in exacerbated unwanted tissue damage. To further examine the interrelationship among insulin signaling, neuroinflammation and RAS in the brain, the effect of repeated lipopolysaccharide (LPS) exposure and co-treatment with the angiotensin II (Ang II) receptor type 1 (AT1) blocker, candesartan (Cand), on anxiety and depression-like behaviors, RAS, neuroinflammation and insulin signaling was explored. Our results demonstrated that prolonged LPS challenge successfully induced the rats into anxiety and depression-like state, accompanied with significant neural apoptosis and neuroinflammation. LPS also activated RAS as evidenced by the enhanced angiotensin converting enzyme (ACE) expression, Ang II generation and AT1 expression. However, blocking the activated RAS with Cand co-treatment conferred neurobehavioral protective properties. The AT1 blocker markedly ameliorated the microglial activation, the enhanced gene expression of the proinflammatory cytokines and the overactivated NF-κB signaling. In addition, Cand also mitigated the LPS-induced disturbance of insulin signaling with the normalized phosphorylation of serine 307 and tyrosine 896 of insulin receptor substrate-1 (IRS-1). Collectively, the present study, for the first time, provided the direct evidence indicating that the inflammatory condition may interact with RAS to impede brain insulin pathway, resulting in neurobehavioral damage, and inhibiting RAS seems to be a promising strategy to block the cross-talk and cut off the vicious cycle between RAS and immune system. Frontiers Media S.A. 2019-04-02 /pmc/articles/PMC6454872/ /pubmed/31001119 http://dx.doi.org/10.3389/fphar.2019.00318 Text en Copyright © 2019 Gong, Hu, Qiao, Xu, Yang, Dang, Han, Guo, Chen and Jiang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Gong, Xiaoxue Hu, Hui Qiao, Yi Xu, Pengfei Yang, Mengqi Dang, Ruili Han, Wenxiu Guo, Yujin Chen, Dan Jiang, Pei The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling |
title | The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling |
title_full | The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling |
title_fullStr | The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling |
title_full_unstemmed | The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling |
title_short | The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling |
title_sort | involvement of renin-angiotensin system in lipopolysaccharide-induced behavioral changes, neuroinflammation, and disturbed insulin signaling |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454872/ https://www.ncbi.nlm.nih.gov/pubmed/31001119 http://dx.doi.org/10.3389/fphar.2019.00318 |
work_keys_str_mv | AT gongxiaoxue theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT huhui theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT qiaoyi theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT xupengfei theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT yangmengqi theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT dangruili theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT hanwenxiu theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT guoyujin theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT chendan theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT jiangpei theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT gongxiaoxue involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT huhui involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT qiaoyi involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT xupengfei involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT yangmengqi involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT dangruili involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT hanwenxiu involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT guoyujin involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT chendan involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling AT jiangpei involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling |